Boston Scientific Corporation

BSX: NYSE
76Total

Lowest reading is at 66 out of 100. All scores are out of 100.

About The Company

CEO

Mr. Michael F. Mahoney

Market Cap

63.65 Billion USD

Sector

Healthcare

Website

https://www.bostonscientific.com

Last Update

27/09/2026, 17:02:39

Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

Read More

Strongest readings

  • ✔Cashflow and earnings growth is strong (growth score 89 out of 100)
  • ✔Debt is low at 0.47 times equity
  • ✔Financial health is strong (health score 68 out of 100)
  • ✔Price-to-earnings of 17.7 is below the market average of 19.6

Weakest readings

  • ✘The current price sits above estimated fair value (margin of safety -59.56%)
  • ✘Share count has been rising at 0.88% per year

Key Figures

StatusMetricValueReadingMarket avg
✔
Price / earnings (TTM)
17.69x
19.60x
✘
Margin of safety (DCF)
-59.56%
17.95%
✔
Revenue growth (5y average)
17.61%
10.97%
✘
Dividend yield (TTM)
0.00%
1.85%
✘
Share count, per year
0.88%
0.00%
✘Return on capital employed9.45%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

66 / 100

Priced at or below the market on most measures.

StatusMetricValueReadingMarket avg
✔
Price / earnings
17.69x
19.60x
✔Free cashflow yield5.70%
4.70%
✔Price / earnings growth0.32x
1.50x
Price / book2.55x
—
✘
Margin of safety
-59.56%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 17.76 USD is below the current price of 43.92 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 30.5 USD ✘

Current Price: 43.9 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

89 / 100

Growing faster than the market on most measures.

StatusMetricValueReadingMarket avg
✔
Revenue growth
17.61%
10.97%
✔Earnings growth36.11%
14.48%
✔Cashflow growth38.30%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Revenue growth has slowed this year (13.52% against a five year average of 17.61%)
  • ✔Earnings growth has improved this year (45.81% against a five year average of 36.11%)
  • ✘Free cashflow growth has slowed this year

Health

68 / 100

Balance sheet covers its obligations.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
✘Altman-Z score2.97
3.00
✔Piotroski score7.00
5.00
✔Debt / equity0.47x
0.80x
✔Current ratio1.62x
1.00x
✔Interest coverage10.35x
2.50x
✔Free cashflow / debt0.32x
0.15x
✔Debt / capital0.32x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Management

    81 / 100

    Returns on capital are at or above the market.

    StatusMetricValueReadingMarket avg
    ✘Return on equity11.93%
    15.00%
    ✘Return on capital employed9.45%
    10.00%
    Return on assets6.62%
    —
    Free cashflow return on capital9.57%
    —
    ✔Return on capital, 5y change6.67%
    0.00%
    ✘
    Share count, per year
    0.88%
    0.00%
    ✔Share count, recent-2.11%
    0.00%
    Realized buyback returnN/A0.00%
    ✔Goodwill erosion / equity0.00%
    2.00%
    Price volatility, 5 year22.44%
    —

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘New shares were issued while the value score was 66 out of 100

    Analysts

    not enough data
    StatusMetricValueReadingNeutral
    Analyst opinion scoreN/A50

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Financial History

    Annual figures across the full reporting history we hold.

    Market Peers

    BSX

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    See 35+ Years Annual Reports

    Other Information

    Company Name

    Boston Scientific Corporation

    Currency

    USD

    Beta

    0.568

    Vol Avg

    20545711

    Ceo

    Mr. Michael F. Mahoney

    Cik

    0000885725

    Cusip

    Exchange

    NYSE

    Full Time Employees

    59000

    Industry

    Medical Devices

    Sector

    Healthcare

    Ipo Date

    Address

    300 Boston Scientific Way

    City

    Marlborough

    State

    MA

    Country

    United States

    Zip

    01752-1234

    Phone

    508 683 4000

    Analysis Last Updated

    27/09/2026, 17:02:39

    Financial data compiled from SEC EDGAR filings and Yahoo Finance.

    Noticed an error with something on our site?

    Data, not advice. Do your own diligence.

    We Use Cookies